Video Experimental Relacionado
Updated: Sep 8, 2025
04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.2K
El ARN largo no codificante SNHG12 define la estabilidad de KEAP1 y la susceptibilidad a la ferroposis al apuntar a
Yubo Guo1, Shuang Zhu2, Wenjie Wu3
1State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China; Hubei Hongshan Laboratory, Wuhan, Hubei, 430070, China.
The Journal of biological chemistry
|September 6, 2025
Resumen
Este estudio identifica SNHG12 como un nuevo regulador de la ferroptosis, un tipo de muerte celular crucial para la terapia del cáncer. La upregulación de SNHG12 promueve la ferroposis al interactuar con TRIM25, ofreciendo nuevas dianas terapéuticas.
Área de la Ciencia:
- Biología molecular
- Investigación de la muerte celular
- Terapia contra el cáncer
Sus antecedentes:
- La ferroposis, una forma de muerte celular programada dependiente del hierro, es una vía prometedora para el tratamiento del cáncer.
- Los ARN largos no codificantes (ARNlnc) como el SNHG son cada vez más reconocidos por su papel en la progresión del cáncer y la resistencia a los medicamentos.
Objetivo del estudio:
- Investigar el papel de SNHG12 en la regulación de la ferroptosis.
- Para aclarar el mecanismo molecular por el cual SNHG12 modula la ferroposis.
- Explorar el potencial terapéutico de dirigirse a la vía mediada por SNHG12 en el cáncer.
Principales métodos:
- PCR cuantitativa en tiempo real para evaluar la expresión de SNHG12.
- Ensayos de viabilidad celular y de hierro para medir la ferroptosis.
- Immunoprecipitación de ARN y borrado occidental para analizar las interacciones moleculares.
- La edición del gen CRISPR-Cas9 para manipular la expresión de SNHG12.
Principales resultados:
- La expresión de SNHG12 se regula al alza durante la inducción de la ferroposis, potencialmente regulada por P53.
- El silenciamiento de SNHG12 inhibe la ferroposis, mientras que su sobreexpresión la acelera.
- SNHG12 interactúa con TRIM25, impidiendo la degradación de KEAP1 y por lo tanto suprimiendo la respuesta antioxidante NRF2.
- Este mecanismo conduce a un aumento del hierro labile intracelular y al agotamiento de la GSH, sensibilizando las células cancerosas a la ferroposis.
Conclusiones:
- SNHG12 actúa como un nuevo lncRNA promotor de la ferroposis en las células cancerosas.
- Un nuevo eje regulador que involucra a SNHG12, TRIM25 y KEAP1 controla la ferroposis.
- Dirigirse a la vía SNHG12-TRIM25-KEAP1 presenta una estrategia potencial para mejorar la terapia contra el cáncer basada en la ferroposis.
Videos de Conceptos Relacionados
01:31Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
01:29Protein Folding Quality Check in the RER
3.8K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.8K
01:37The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
01:32Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
02:04Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
02:18Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K